2013 Q4 Form 10-K Financial Statement
#000104746914001864 Filed on March 06, 2014
Income Statement
| Concept | 2013 Q4 | 2013 Q3 | 2013 Q2 |
|---|---|---|---|
| Revenue | $0.00 | $0.00 | $11.50M |
| YoY Change | |||
| Cost Of Revenue | |||
| YoY Change | |||
| Gross Profit | |||
| YoY Change | |||
| Gross Profit Margin | |||
| Selling, General & Admin | $5.970M | $4.750M | $7.540M |
| YoY Change | 40.47% | 30.14% | 236.61% |
| % of Gross Profit | |||
| Research & Development | $9.630M | $12.10M | $12.23M |
| YoY Change | -16.91% | 111.97% | 57.84% |
| % of Gross Profit | |||
| Depreciation & Amortization | $200.0K | $180.0K | $150.0K |
| YoY Change | 33.33% | 28.57% | 15.38% |
| % of Gross Profit | |||
| Operating Expenses | $15.59M | $16.84M | $19.77M |
| YoY Change | -1.58% | 80.07% | 98.03% |
| Operating Profit | -$15.59M | -$16.84M | -$8.269M |
| YoY Change | -1.54% | 80.07% | -17.17% |
| Interest Expense | -$590.0K | $525.0K | $635.0K |
| YoY Change | -255.26% | 136.49% | 63400.0% |
| % of Operating Profit | |||
| Other Income/Expense, Net | -$40.00K | $0.00 | $0.00 |
| YoY Change | |||
| Pretax Income | -$16.21M | -$17.33M | -$8.854M |
| YoY Change | 4.85% | 84.68% | -8.67% |
| Income Tax | $0.00 | $0.00 | $0.00 |
| % Of Pretax Income | |||
| Net Earnings | -$16.21M | -$17.33M | -$8.854M |
| YoY Change | 4.94% | 84.68% | -8.68% |
| Net Earnings / Revenue | -76.99% | ||
| Basic Earnings Per Share | |||
| Diluted Earnings Per Share | -$413.6K | -$463.5K | -$278.7K |
| COMMON SHARES | |||
| Basic Shares Outstanding | 39.11M shares | 37.39M shares | 31.75M shares |
| Diluted Shares Outstanding | 37.39M shares | 31.75M shares |
Balance Sheet
| Concept | 2013 Q4 | 2013 Q3 | 2013 Q2 |
|---|---|---|---|
| SHORT-TERM ASSETS | |||
| Cash & Short-Term Investments | $113.9M | $128.0M | $76.80M |
| YoY Change | 22.6% | 42.7% | 5.06% |
| Cash & Equivalents | $113.9M | $128.0M | $74.59M |
| Short-Term Investments | |||
| Other Short-Term Assets | $2.300M | $1.700M | $1.800M |
| YoY Change | 283.33% | 183.33% | 157.14% |
| Inventory | |||
| Prepaid Expenses | |||
| Receivables | |||
| Other Receivables | |||
| Total Short-Term Assets | $116.2M | $129.7M | $78.57M |
| YoY Change | 24.13% | 43.52% | 6.31% |
| LONG-TERM ASSETS | |||
| Property, Plant & Equipment | $1.812M | $1.904M | $1.900M |
| YoY Change | 8.76% | 19.0% | 5.56% |
| Goodwill | |||
| YoY Change | |||
| Intangibles | |||
| YoY Change | |||
| Long-Term Investments | |||
| YoY Change | |||
| Other Assets | $300.0K | $100.0K | $100.0K |
| YoY Change | 200.0% | 0.0% | 0.0% |
| Total Long-Term Assets | $60.34M | $60.21M | $60.16M |
| YoY Change | 0.59% | -3.05% | -3.28% |
| TOTAL ASSETS | |||
| Total Short-Term Assets | $116.2M | $129.7M | $78.57M |
| Total Long-Term Assets | $60.34M | $60.21M | $60.16M |
| Total Assets | $176.5M | $190.0M | $138.7M |
| YoY Change | 14.94% | 24.56% | 1.93% |
| SHORT-TERM LIABILITIES | |||
| YoY Change | |||
| Accounts Payable | $5.929M | $4.661M | $7.900M |
| YoY Change | -16.02% | 55.37% | 146.88% |
| Accrued Expenses | $3.905M | $5.652M | $3.188M |
| YoY Change | 33.14% | 109.33% | 6.27% |
| Deferred Revenue | |||
| YoY Change | |||
| Short-Term Debt | $0.00 | $0.00 | $0.00 |
| YoY Change | |||
| Long-Term Debt Due | $3.283M | $7.055M | $4.700M |
| YoY Change | 9.18% | 907.86% | 4600.0% |
| Total Short-Term Liabilities | $16.46M | $19.82M | $18.10M |
| YoY Change | 4.5% | 204.95% | 178.48% |
| LONG-TERM LIABILITIES | |||
| Long-Term Debt | $16.34M | $12.54M | $14.89M |
| YoY Change | 0.72% | 45.79% | 63.67% |
| Other Long-Term Liabilities | $400.0K | $400.0K | $500.0K |
| YoY Change | -33.33% | -42.86% | -37.5% |
| Total Long-Term Liabilities | $16.34M | $12.54M | $14.89M |
| YoY Change | 0.72% | 34.82% | 50.44% |
| TOTAL LIABILITIES | |||
| Total Short-Term Liabilities | $16.46M | $19.82M | $18.10M |
| Total Long-Term Liabilities | $16.34M | $12.54M | $14.89M |
| Total Liabilities | $33.17M | $32.83M | $33.00M |
| YoY Change | 1.51% | 107.75% | 102.42% |
| SHAREHOLDERS EQUITY | |||
| Retained Earnings | -$391.6M | -$375.4M | |
| YoY Change | 16.71% | ||
| Common Stock | $391.0K | $391.0K | |
| YoY Change | 24.13% | ||
| Preferred Stock | |||
| YoY Change | |||
| Treasury Stock (at cost) | |||
| YoY Change | |||
| Treasury Stock Shares | |||
| Shareholders Equity | $143.3M | $157.1M | $105.2M |
| YoY Change | |||
| Total Liabilities & Shareholders Equity | $176.5M | $190.0M | $138.7M |
| YoY Change | 14.94% | 24.56% | 1.93% |
Cashflow Statement
| Concept | 2013 Q4 | 2013 Q3 | 2013 Q2 |
|---|---|---|---|
| OPERATING ACTIVITIES | |||
| Net Income | -$16.21M | -$17.33M | -$8.854M |
| YoY Change | 4.94% | 84.68% | -8.68% |
| Depreciation, Depletion And Amortization | $200.0K | $180.0K | $150.0K |
| YoY Change | 33.33% | 28.57% | 15.38% |
| Cash From Operating Activities | -$14.05M | -$16.29M | -$5.110M |
| YoY Change | 57.51% | 77.26% | -29.9% |
| INVESTING ACTIVITIES | |||
| Capital Expenditures | -$120.0K | -$220.0K | -$330.0K |
| YoY Change | -29.41% | 1000.0% | 1000.0% |
| Acquisitions | |||
| YoY Change | |||
| Other Investing Activities | $0.00 | $2.160M | $0.00 |
| YoY Change | -100.0% | -100.0% | |
| Cash From Investing Activities | -$110.0K | $1.930M | -$330.0K |
| YoY Change | -100.25% | -6533.33% | -108.01% |
| FINANCING ACTIVITIES | |||
| Cash Dividend Paid | |||
| YoY Change | |||
| Common Stock Issuance & Retirement, Net | $67.00M | ||
| YoY Change | 160.7% | ||
| Debt Paid & Issued, Net | |||
| YoY Change | |||
| Cash From Financing Activities | 40.00K | 67.79M | 600.0K |
| YoY Change | -99.61% | 164.49% | -93.81% |
| NET CHANGE | |||
| Cash From Operating Activities | -14.05M | -16.29M | -5.110M |
| Cash From Investing Activities | -110.0K | 1.930M | -330.0K |
| Cash From Financing Activities | 40.00K | 67.79M | 600.0K |
| Net Change In Cash | -14.12M | 53.43M | -4.840M |
| YoY Change | -130.83% | 225.59% | -174.23% |
| FREE CASH FLOW | |||
| Cash From Operating Activities | -$14.05M | -$16.29M | -$5.110M |
| Capital Expenditures | -$120.0K | -$220.0K | -$330.0K |
| Free Cash Flow | -$13.93M | -$16.07M | -$4.780M |
| YoY Change | 59.2% | 75.25% | -34.16% |
Facts In Submission
| Frame | Concept Type | Concept / XBRL Key | Value | Unit |
|---|---|---|---|---|
| CY2013Q4 | us-gaap |
Available For Sale Securities Continuous Unrealized Loss Position Fair Value
AvailableForSaleSecuritiesContinuousUnrealizedLossPositionFairValue
|
0 | USD |
| CY2013 | us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
34980000 | shares |
| CY2012 | us-gaap |
Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
|
26545000 | shares |
| CY2012Q4 | us-gaap |
Available For Sale Securities Continuous Unrealized Loss Position Fair Value
AvailableForSaleSecuritiesContinuousUnrealizedLossPositionFairValue
|
0 | USD |
| CY2013Q4 | us-gaap |
Unrecognized Tax Benefits
UnrecognizedTaxBenefits
|
0 | USD |
| CY2013 | us-gaap |
Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
|
-56073000 | USD |
| CY2012 | us-gaap |
Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
|
-41374000 | USD |
| CY2011 | us-gaap |
Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
|
-68839000 | USD |
| CY2012 | us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
26545000 | shares |
| CY2011 | us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
23348000 | shares |
| CY2013 | us-gaap |
Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
|
34980000 | shares |
| CY2011 | us-gaap |
Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
|
23348000 | shares |
| CY2013 | insm |
Number Of Initial Indications In Orphan Patient Populations For Which Clinical Trials Conducted
NumberOfInitialIndicationsInOrphanPatientPopulationsForWhichClinicalTrialsConducted
|
2 | item |
| CY2013 | us-gaap |
Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
|
-1.60 | |
| CY2012 | us-gaap |
Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
|
-1.56 | |
| CY2011 | us-gaap |
Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
|
-2.95 | |
| CY2011 | us-gaap |
Impairment Of Intangible Assets Indefinitelived Excluding Goodwill
ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill
|
19700000 | USD |
| CY2013 | us-gaap |
Number Of Reportable Segments
NumberOfReportableSegments
|
1 | item |
| CY2013 | us-gaap |
Use Of Estimates
UseOfEstimates
|
<div style="font-size:10.0pt;font-family:Times New Roman;"> <p style="FONT-FAMILY: times;"><font size="2"><b><i>              Use of Estimates</i></b></font><font size="2">—The preparation of the consolidated financial statements in conformity with accounting principles generally accepted in the United States (GAAP) requires management to make estimates and assumptions that affect the amounts reported in the consolidated financial statements and accompanying notes. The Company bases its estimates and judgments on historical experience and on various other assumptions that it believes are reasonable under the circumstances. The amounts of assets and liabilities reported in the Company's balance sheets and the amounts of revenue and expenses reported for each period presented are effected by estimates and assumptions, which are used for, but not limited to, the accounting for revenue recognition, stock-based compensation, income taxes, loss contingencies, the beneficial conversion charge, the warrant fair value calculation, impairment of intangibles and long lived assets and accounting for research and development costs. Actual results could differ from those estimates.</font></p> </div> | |
| CY2013 | us-gaap |
Prior Period Reclassification Adjustment Description
PriorPeriodReclassificationAdjustmentDescription
|
<div style="font-size:10.0pt;font-family:Times New Roman;"> <p style="FONT-FAMILY: times;"><font size="2"><b><i>              Prior Period Reclassifications</i></b></font><font size="2">—Certain amounts in the 2011 consolidated financial statements were reclassified to conform to the 2012 presentation. Specifically, the Company allocated a portion of certain operating expenses from general and administrative expense to research and development expense in 2012 and recast the 2011 amounts to conform to the current year presentation for comparability purposes.</font></p> </div> | |
| CY2013 | us-gaap |
Other Sales Revenue Net
OtherSalesRevenueNet
|
11500000 | USD |
| CY2013 | us-gaap |
Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
|
<div style="font-size:10.0pt;font-family:Times New Roman;"> <p style="FONT-FAMILY: times;"><font size="2"><b><i>              Concentration of Credit Risk</i></b></font><font size="2">—Financial instruments that potentially subject the Company to concentrations of credit risk consist primarily of cash, cash equivalents and short-term investments. The Company places its cash equivalents with high credit-quality financial institutions and may invest its short-term investments in US treasury securities, mutual funds and government agency bonds. The Company has established guidelines relative to credit ratings and maturities that seek to maintain safety and liquidity.</font></p> <p style="FONT-FAMILY: times;"><font size="2">              The Company sources its raw materials from single suppliers. In addition, the production of the Company's product candidate is performed by a sole manufacturer. The inability of the suppliers or manufacturer to fulfill supply requirements of the Company could materially impact future operating results. A change in the relationship with the suppliers or manufacturer, or an adverse change in their business, could materially impact future operating results.</font></p> </div> | |
| CY2013 | us-gaap |
Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
|
-33000 | USD |
| CY2011Q4 | us-gaap |
Debt Instrument Convertible Conversion Price1
DebtInstrumentConvertibleConversionPrice1
|
1.00 | |
| CY2013Q4 | insm |
Accrued Clinical Trial Expenses
AccruedClinicalTrialExpenses
|
2484000 | USD |
| CY2013Q4 | us-gaap |
Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
|
24000 | USD |
| CY2013Q4 | us-gaap |
Interest Payable Current
InterestPayableCurrent
|
159000 | USD |
| CY2013Q4 | us-gaap |
Accrued Liabilities Current
AccruedLiabilitiesCurrent
|
3905000 | USD |
| CY2012Q4 | insm |
Accrued Clinical Trial Expenses
AccruedClinicalTrialExpenses
|
1460000 | USD |
| CY2012Q4 | insm |
Liability For Stock Based Compensation Awards
LiabilityForStockBasedCompensationAwards
|
1204000 | USD |
| CY2012Q4 | us-gaap |
Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
|
185000 | USD |
| CY2012Q4 | us-gaap |
Interest Payable Current
InterestPayableCurrent
|
80000 | USD |
| CY2013Q4 | us-gaap |
Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
|
18000 | USD |
| CY2012Q4 | us-gaap |
Accrued Liabilities Current
AccruedLiabilitiesCurrent
|
2933000 | USD |
| CY2013Q4 | us-gaap |
Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
|
5374000 | USD |
| CY2012Q4 | us-gaap |
Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
|
4548000 | USD |
| CY2013Q4 | us-gaap |
Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
|
3562000 | USD |
| CY2012Q4 | us-gaap |
Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
|
2882000 | USD |
| CY2013Q4 | us-gaap |
Capital Lease Obligations
CapitalLeaseObligations
|
100000 | USD |
| CY2012Q4 | us-gaap |
Capital Lease Obligations
CapitalLeaseObligations
|
300000 | USD |
| CY2012 | us-gaap |
Effective Income Tax Rate Reconciliation Nondeductible Expense Research And Development
EffectiveIncomeTaxRateReconciliationNondeductibleExpenseResearchAndDevelopment
|
0.01 | pure |
| CY2013Q3 | us-gaap |
Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
|
4700000 | USD |
| CY2013Q4 | insm |
Number Of Equity Compensation Plans
NumberOfEquityCompensationPlans
|
3 | item |
| CY2013Q4 | us-gaap |
Secured Debt
SecuredDebt
|
20000000 | USD |
| CY2013Q4 | insm |
Additional Charge At End Of Term
AdditionalChargeAtEndOfTerm
|
204000 | USD |
| CY2013Q4 | us-gaap |
Unamortized Debt Issuance Expense
UnamortizedDebtIssuanceExpense
|
215000 | USD |
| CY2013Q4 | insm |
Unamortized Discount From Warrant
UnamortizedDiscountFromWarrant
|
368000 | USD |
| CY2013Q4 | us-gaap |
Debt Current
DebtCurrent
|
3283000 | USD |
| CY2013Q4 | us-gaap |
Long Term Debt Noncurrent
LongTermDebtNoncurrent
|
16338000 | USD |
| CY2013Q4 | us-gaap |
Long Term Debt Maturities Repayments Of Principal In Year Two
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo
|
7785000 | USD |
| CY2013Q4 | us-gaap |
Long Term Debt Maturities Repayments Of Principal In Year Three
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree
|
8589000 | USD |
| CY2013Q4 | us-gaap |
Long Term Debt
LongTermDebt
|
20000000 | USD |
| CY2013Q4 | us-gaap |
Common Stock Shares Authorized
CommonStockSharesAuthorized
|
500000000 | shares |
| CY2013Q4 | us-gaap |
Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
|
0.01 | |
| CY2013Q4 | us-gaap |
Common Stock Shares Issued
CommonStockSharesIssued
|
39137679 | shares |
| CY2013Q4 | us-gaap |
Common Stock Shares Outstanding
CommonStockSharesOutstanding
|
39137679 | shares |
| CY2013Q3 | us-gaap |
Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
|
6900000 | shares |
| CY2013Q3 | insm |
Common Stock Shares Exercise To Underwriters In Full Of Over Allotment Option
CommonStockSharesExerciseToUnderwritersInFullOfOverAllotmentOption
|
900000 | shares |
| CY2013Q3 | us-gaap |
Share Price
SharePrice
|
10.40 | |
| CY2013Q3 | us-gaap |
Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
|
67000000 | USD |
| CY2011 | us-gaap |
Effective Income Tax Rate Reconciliation Nondeductible Expense Research And Development
EffectiveIncomeTaxRateReconciliationNondeductibleExpenseResearchAndDevelopment
|
0.05 | pure |
| CY2012 | insm |
Effective Income Tax Rate Reconciliation Expired Net Operating Loss Carryforwards
EffectiveIncomeTaxRateReconciliationExpiredNetOperatingLossCarryforwards
|
-0.15 | pure |
| CY2012Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
|
438145 | shares |
| CY2010Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
|
214275 | shares |
| CY2011Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
|
891751 | shares |
| CY2012Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
|
1817839 | shares |
| CY2013Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
|
3632996 | shares |
| CY2011 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
|
766000 | shares |
| CY2012 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
|
1116384 | shares |
| CY2013 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
|
2323500 | shares |
| CY2011 | us-gaap |
Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
|
5200 | shares |
| CY2012 | us-gaap |
Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
|
30250 | shares |
| CY2013 | us-gaap |
Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
|
371743 | shares |
| CY2011 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
|
83324 | shares |
| CY2012 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
|
160046 | shares |
| CY2013 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
|
136600 | shares |
| CY2011Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
|
816414 | shares |
| CY2012Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
|
1692915 | shares |
| CY2013Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
|
3402306 | shares |
| CY2011Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
|
125751 | shares |
| CY2013Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
|
484213 | shares |
| CY2010Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
|
18.43 | |
| CY2011Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
|
5.15 | |
| CY2012Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
|
4.10 | |
| CY2013Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
|
7.94 | |
| CY2011 | us-gaap |
Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
|
3.77 | |
| CY2012 | us-gaap |
Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
|
4.12 | |
| CY2013 | us-gaap |
Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
|
10.53 | |
| CY2011 | us-gaap |
Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
|
6.16 | |
| CY2012 | us-gaap |
Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
|
7.08 | |
| CY2013 | us-gaap |
Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
|
4.37 | |
| CY2011 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
|
26.57 | |
| CY2012 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
|
9.54 | |
| CY2013 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
|
10.49 | |
| CY2011Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice
|
5.30 | |
| CY2012Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice
|
4.11 | |
| CY2013Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice
|
7.88 | |
| CY2011Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
|
13.54 | |
| CY2013Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
|
4.25 | |
| CY2013 | us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
|
P8Y11M5D | |
| CY2013 | us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1
|
P8Y10M28D | |
| CY2013 | us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
|
P7Y4M10D | |
| CY2013Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
|
32903657 | USD |
| CY2013Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue
|
31012054 | USD |
| CY2013Q4 | us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
|
6176106 | USD |
| CY2013Q4 | insm |
Accrued Technical Operation Expenses
AccruedTechnicalOperationExpenses
|
1220000 | USD |
| CY2013 | insm |
Effective Income Tax Rate Reconciliation Change In State Tax Rate
EffectiveIncomeTaxRateReconciliationChangeInStateTaxRate
|
0.02 | pure |
| CY2013Q4 | us-gaap |
Accrued Rent Current
AccruedRentCurrent
|
307000 | USD |
| CY2012 | us-gaap |
Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
|
0.04 | pure |
| CY2011 | us-gaap |
Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
|
0.03 | pure |
| CY2013 | us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
-1221000 | USD |
| CY2013 | us-gaap |
Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
|
0.020 | pure |
| CY2011 | us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
0 | USD |
| CY2012 | us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
0 | USD |
| CY2012 | us-gaap |
Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
|
0.000 | pure |
| CY2011 | us-gaap |
Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
|
0.000 | pure |
| CY2013Q2 | us-gaap |
Revenues
Revenues
|
11500000 | USD |
| CY2013 | us-gaap |
Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
|
0.34 | pure |
| CY2013 | us-gaap |
Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
|
0.07 | pure |
| CY2013 | us-gaap |
Effective Income Tax Rate Reconciliation Nondeductible Expense Research And Development
EffectiveIncomeTaxRateReconciliationNondeductibleExpenseResearchAndDevelopment
|
0.07 | pure |
| CY2013 | us-gaap |
Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
|
-0.49 | pure |
| CY2013 | us-gaap |
Effective Income Tax Rate Reconciliation Other Adjustments
EffectiveIncomeTaxRateReconciliationOtherAdjustments
|
0.01 | pure |
| CY2012 | us-gaap |
Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
|
0.34 | pure |
| CY2011 | us-gaap |
Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
|
0.34 | pure |
| CY2011 | insm |
Effective Income Tax Rate Reconciliation Permanent Items
EffectiveIncomeTaxRateReconciliationPermanentItems
|
-0.04 | pure |
| CY2011 | insm |
Effective Income Tax Rate Reconciliation Expired Net Operating Loss Carryforwards
EffectiveIncomeTaxRateReconciliationExpiredNetOperatingLossCarryforwards
|
-0.10 | pure |
| CY2012 | us-gaap |
Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
|
-0.22 | pure |
| CY2011 | us-gaap |
Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
|
-0.27 | pure |
| CY2012 | us-gaap |
Effective Income Tax Rate Reconciliation Other Adjustments
EffectiveIncomeTaxRateReconciliationOtherAdjustments
|
-0.02 | pure |
| CY2011 | us-gaap |
Effective Income Tax Rate Reconciliation Other Adjustments
EffectiveIncomeTaxRateReconciliationOtherAdjustments
|
-0.01 | pure |
| CY2013Q4 | us-gaap |
Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
|
149753000 | USD |
| CY2013Q4 | us-gaap |
Deferred Tax Assets Tax Credit Carryforwards General Business
DeferredTaxAssetsTaxCreditCarryforwardsGeneralBusiness
|
15209000 | USD |
| CY2013Q4 | us-gaap |
Deferred Tax Assets Tax Credit Carryforwards Alternative Minimum Tax
DeferredTaxAssetsTaxCreditCarryforwardsAlternativeMinimumTax
|
418000 | USD |
| CY2013Q4 | us-gaap |
Deferred Tax Assets Other
DeferredTaxAssetsOther
|
5951000 | USD |
| CY2013Q4 | us-gaap |
Deferred Tax Assets Gross
DeferredTaxAssetsGross
|
171331000 | USD |
| CY2012Q4 | us-gaap |
Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
|
128257000 | USD |
| CY2012Q4 | us-gaap |
Deferred Tax Assets Tax Credit Carryforwards General Business
DeferredTaxAssetsTaxCreditCarryforwardsGeneralBusiness
|
10501000 | USD |
| CY2012Q4 | us-gaap |
Deferred Tax Assets Tax Credit Carryforwards Alternative Minimum Tax
DeferredTaxAssetsTaxCreditCarryforwardsAlternativeMinimumTax
|
418000 | USD |
| CY2012Q4 | us-gaap |
Deferred Tax Assets Other
DeferredTaxAssetsOther
|
3007000 | USD |
| CY2012Q4 | us-gaap |
Deferred Tax Assets Gross
DeferredTaxAssetsGross
|
142183000 | USD |
| CY2013Q4 | insm |
Deferred Tax Liabilities In Process Research And Development
DeferredTaxLiabilitiesInProcessResearchAndDevelopment
|
23245000 | USD |
| CY2013 | us-gaap |
Defined Contribution Plan Employer Discretionary Contribution Amount
DefinedContributionPlanEmployerDiscretionaryContributionAmount
|
0 | USD |
| CY2013Q4 | us-gaap |
Deferred Income Tax Liabilities
DeferredIncomeTaxLiabilities
|
23245000 | USD |
| CY2013Q4 | insm |
Deferred Tax Assets Liabilities Net Before Valuation Allowances
DeferredTaxAssetsLiabilitiesNetBeforeValuationAllowances
|
148086000 | USD |
| CY2013Q4 | us-gaap |
Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
|
148086000 | USD |
| CY2012Q4 | insm |
Deferred Tax Liabilities In Process Research And Development
DeferredTaxLiabilitiesInProcessResearchAndDevelopment
|
22093000 | USD |
| CY2012Q4 | us-gaap |
Deferred Income Tax Liabilities
DeferredIncomeTaxLiabilities
|
22093000 | USD |
| CY2012Q4 | insm |
Deferred Tax Assets Liabilities Net Before Valuation Allowances
DeferredTaxAssetsLiabilitiesNetBeforeValuationAllowances
|
120090000 | USD |
| CY2012Q4 | us-gaap |
Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
|
120090000 | USD |
| CY2013 | us-gaap |
Valuation Allowance Deferred Tax Asset Change In Amount
ValuationAllowanceDeferredTaxAssetChangeInAmount
|
28000000 | USD |
| CY2012 | us-gaap |
Defined Contribution Plan Employer Discretionary Contribution Amount
DefinedContributionPlanEmployerDiscretionaryContributionAmount
|
0 | USD |
| CY2013 | us-gaap |
Lease And Rental Expense
LeaseAndRentalExpense
|
1000000 | USD |
| CY2012 | us-gaap |
Lease And Rental Expense
LeaseAndRentalExpense
|
1000000 | USD |
| CY2011 | us-gaap |
Lease And Rental Expense
LeaseAndRentalExpense
|
1000000 | USD |
| CY2013Q4 | us-gaap |
Operating Leases Future Minimum Payments Due In Two Years
OperatingLeasesFutureMinimumPaymentsDueInTwoYears
|
944000 | USD |
| CY2013Q4 | us-gaap |
Operating Leases Future Minimum Payments Due In Three Years
OperatingLeasesFutureMinimumPaymentsDueInThreeYears
|
886000 | USD |
| CY2013Q4 | us-gaap |
Operating Leases Future Minimum Payments Due In Four Years
OperatingLeasesFutureMinimumPaymentsDueInFourYears
|
474000 | USD |
| CY2013Q4 | us-gaap |
Operating Leases Future Minimum Payments Due In Five Years
OperatingLeasesFutureMinimumPaymentsDueInFiveYears
|
488000 | USD |
| CY2013Q4 | us-gaap |
Operating Leases Future Minimum Payments Due
OperatingLeasesFutureMinimumPaymentsDue
|
4489000 | USD |
| CY2013Q4 | us-gaap |
Deferred Rent Credit Current
DeferredRentCreditCurrent
|
129000 | USD |
| CY2013Q4 | us-gaap |
Capital Lease Obligations Current
CapitalLeaseObligationsCurrent
|
64000 | USD |
| CY2013Q4 | us-gaap |
Long Term Debt Current
LongTermDebtCurrent
|
3283000 | USD |
| CY2013Q4 | us-gaap |
Liabilities Current
LiabilitiesCurrent
|
16456000 | USD |
| CY2012Q4 | us-gaap |
Accounts Payable Current
AccountsPayableCurrent
|
7060000 | USD |
| CY2012Q4 | us-gaap |
Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
|
2207000 | USD |
| CY2012Q4 | us-gaap |
Accrued Rent Current
AccruedRentCurrent
|
295000 | USD |
| CY2012Q4 | us-gaap |
Deferred Rent Credit Current
DeferredRentCreditCurrent
|
149000 | USD |
| CY2012Q4 | us-gaap |
Capital Lease Obligations Current
CapitalLeaseObligationsCurrent
|
96000 | USD |
| CY2013Q4 | us-gaap |
Accrued Rent Noncurrent
AccruedRentNoncurrent
|
380000 | USD |
| CY2013 | dei |
Entity Registrant Name
EntityRegistrantName
|
INSMED INC | |
| CY2013 | dei |
Entity Central Index Key
EntityCentralIndexKey
|
0001104506 | |
| CY2013 | dei |
Document Type
DocumentType
|
10-K | |
| CY2013 | dei |
Document Period End Date
DocumentPeriodEndDate
|
2013-12-31 | |
| CY2013 | dei |
Amendment Flag
AmendmentFlag
|
false | |
| CY2013 | dei |
Current Fiscal Year End Date
CurrentFiscalYearEndDate
|
--12-31 | |
| CY2013 | dei |
Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
|
No | |
| CY2013 | dei |
Entity Voluntary Filers
EntityVoluntaryFilers
|
No | |
| CY2013 | dei |
Entity Current Reporting Status
EntityCurrentReportingStatus
|
Yes | |
| CY2013 | dei |
Entity Filer Category
EntityFilerCategory
|
Accelerated Filer | |
| CY2013 | dei |
Document Fiscal Year Focus
DocumentFiscalYearFocus
|
2013 | |
| CY2013 | dei |
Document Fiscal Period Focus
DocumentFiscalPeriodFocus
|
FY | |
| CY2014Q1 | dei |
Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
|
39263837 | shares |
| CY2013Q2 | dei |
Entity Public Float
EntityPublicFloat
|
345200000 | USD |
| CY2013Q4 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
113894000 | USD |
| CY2013Q4 | us-gaap |
Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
|
2269000 | USD |
| CY2013Q4 | us-gaap |
Assets Current
AssetsCurrent
|
116163000 | USD |
| CY2013Q4 | us-gaap |
Other Finite Lived Intangible Assets Gross
OtherFiniteLivedIntangibleAssetsGross
|
58200000 | USD |
| CY2013Q4 | us-gaap |
Other Assets
OtherAssets
|
323000 | USD |
| CY2013Q4 | us-gaap |
Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
|
1812000 | USD |
| CY2013Q4 | us-gaap |
Assets
Assets
|
176498000 | USD |
| CY2013Q4 | us-gaap |
Accounts Payable Current
AccountsPayableCurrent
|
5929000 | USD |
| CY2013Q4 | us-gaap |
Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
|
2839000 | USD |
| CY2013Q4 | us-gaap |
Liabilities
Liabilities
|
33174000 | USD |
| CY2012Q4 | us-gaap |
Long Term Debt Current
LongTermDebtCurrent
|
3007000 | USD |
| CY2012 | us-gaap |
General And Administrative Expense
GeneralAndAdministrativeExpense
|
12657000 | USD |
| CY2012 | us-gaap |
Operating Expenses
OperatingExpenses
|
42438000 | USD |
| CY2012Q4 | us-gaap |
Liabilities Current
LiabilitiesCurrent
|
15747000 | USD |
| CY2012Q4 | us-gaap |
Accrued Rent Noncurrent
AccruedRentNoncurrent
|
647000 | USD |
| CY2012 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-42438000 | USD |
| CY2012Q4 | us-gaap |
Capital Lease Obligations Noncurrent
CapitalLeaseObligationsNoncurrent
|
64000 | USD |
| CY2012Q4 | us-gaap |
Long Term Debt Noncurrent
LongTermDebtNoncurrent
|
16221000 | USD |
| CY2013 | us-gaap |
Gain Loss On Disposition Of Assets
GainLossOnDispositionOfAssets
|
2000 | USD |
| CY2012 | us-gaap |
Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
|
5000 | USD |
| CY2012Q4 | us-gaap |
Liabilities
Liabilities
|
32679000 | USD |
| CY2013 | us-gaap |
Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
|
-57294000 | USD |
| CY2013 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-56073000 | USD |
| CY2013 | us-gaap |
Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
|
34980000 | shares |
| CY2013 | us-gaap |
Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
|
-56073000 | USD |
| CY2012 | us-gaap |
Research And Development Expense
ResearchAndDevelopmentExpense
|
29781000 | USD |
| CY2013Q4 | us-gaap |
Common Stock Value
CommonStockValue
|
391000 | USD |
| CY2013Q4 | us-gaap |
Additional Paid In Capital
AdditionalPaidInCapital
|
534554000 | USD |
| CY2013Q4 | us-gaap |
Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
|
-391621000 | USD |
| CY2013Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
143324000 | USD |
| CY2013Q4 | us-gaap |
Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
|
176498000 | USD |
| CY2012Q4 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
90782000 | USD |
| CY2012Q4 | us-gaap |
Certificates Of Deposit At Carrying Value
CertificatesOfDepositAtCarryingValue
|
2153000 | USD |
| CY2012Q4 | us-gaap |
Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
|
643000 | USD |
| CY2012Q4 | us-gaap |
Assets Current
AssetsCurrent
|
93578000 | USD |
| CY2012Q4 | us-gaap |
Other Finite Lived Intangible Assets Gross
OtherFiniteLivedIntangibleAssetsGross
|
58200000 | USD |
| CY2012Q4 | us-gaap |
Other Assets
OtherAssets
|
117000 | USD |
| CY2012Q4 | us-gaap |
Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
|
1666000 | USD |
| CY2012Q4 | us-gaap |
Assets
Assets
|
153561000 | USD |
| CY2012Q4 | us-gaap |
Common Stock Value
CommonStockValue
|
315000 | USD |
| CY2012Q4 | us-gaap |
Additional Paid In Capital
AdditionalPaidInCapital
|
455325000 | USD |
| CY2012Q4 | us-gaap |
Warrants And Rights Outstanding
WarrantsAndRightsOutstanding
|
790000 | USD |
| CY2012Q4 | us-gaap |
Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
|
-335548000 | USD |
| CY2012Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
120882000 | USD |
| CY2012Q4 | us-gaap |
Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
|
153561000 | USD |
| CY2012Q4 | us-gaap |
Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
|
0.01 | |
| CY2012Q4 | us-gaap |
Common Stock Shares Authorized
CommonStockSharesAuthorized
|
500000000 | shares |
| CY2012Q4 | us-gaap |
Common Stock Shares Issued
CommonStockSharesIssued
|
31488204 | shares |
| CY2012Q4 | us-gaap |
Common Stock Shares Outstanding
CommonStockSharesOutstanding
|
31488204 | shares |
| CY2011 | us-gaap |
Licenses Revenue
LicensesRevenue
|
1002000 | USD |
| CY2011 | us-gaap |
Revenue Other Manufactured Products
RevenueOtherManufacturedProducts
|
3415000 | USD |
| CY2013 | us-gaap |
Revenues
Revenues
|
11500000 | USD |
| CY2011 | us-gaap |
Revenues
Revenues
|
4417000 | USD |
| CY2013 | us-gaap |
Research And Development Expense
ResearchAndDevelopmentExpense
|
44279000 | USD |
| CY2013 | us-gaap |
General And Administrative Expense
GeneralAndAdministrativeExpense
|
22236000 | USD |
| CY2013 | us-gaap |
Operating Expenses
OperatingExpenses
|
66515000 | USD |
| CY2013 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-55015000 | USD |
| CY2013 | us-gaap |
Investment Income Nonoperating
InvestmentIncomeNonoperating
|
166000 | USD |
| CY2013 | us-gaap |
Interest Expense
InterestExpense
|
2412000 | USD |
| CY2012 | us-gaap |
Investment Income Nonoperating
InvestmentIncomeNonoperating
|
1822000 | USD |
| CY2012 | us-gaap |
Interest Expense
InterestExpense
|
763000 | USD |
| CY2012 | us-gaap |
Gain Loss On Disposition Of Assets
GainLossOnDispositionOfAssets
|
5000 | USD |
| CY2012 | us-gaap |
Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
|
-41374000 | USD |
| CY2012 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-41374000 | USD |
| CY2012 | us-gaap |
Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
|
26545000 | shares |
| CY2011 | us-gaap |
Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
|
286000 | USD |
| CY2011 | us-gaap |
Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
|
214000 | USD |
| CY2013 | us-gaap |
Repayments Of Long Term Capital Lease Obligations
RepaymentsOfLongTermCapitalLeaseObligations
|
96000 | USD |
| CY2013 | us-gaap |
Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
|
67017000 | USD |
| CY2013 | us-gaap |
Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
|
1626000 | USD |
| CY2012 | us-gaap |
Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
|
4726000 | USD |
| CY2013 | us-gaap |
Proceeds From Maturities Prepayments And Calls Of Shortterm Investments
ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments
|
2153000 | USD |
| CY2013 | us-gaap |
Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
|
1329000 | USD |
| CY2012 | us-gaap |
Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
|
-41824000 | USD |
| CY2011 | us-gaap |
Research And Development Expense
ResearchAndDevelopmentExpense
|
28623000 | USD |
| CY2011 | us-gaap |
General And Administrative Expense
GeneralAndAdministrativeExpense
|
11523000 | USD |
| CY2011 | us-gaap |
Asset Impairment Charges
AssetImpairmentCharges
|
25990000 | USD |
| CY2011 | us-gaap |
Operating Expenses
OperatingExpenses
|
66136000 | USD |
| CY2011 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-61719000 | USD |
| CY2011 | us-gaap |
Investment Income Nonoperating
InvestmentIncomeNonoperating
|
2064000 | USD |
| CY2011 | us-gaap |
Interest Expense
InterestExpense
|
10000 | USD |
| CY2011 | us-gaap |
Gain Loss On Disposition Of Assets
GainLossOnDispositionOfAssets
|
1000 | USD |
| CY2011 | us-gaap |
Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
|
-59664000 | USD |
| CY2011 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-59664000 | USD |
| CY2011 | us-gaap |
Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
|
23348000 | shares |
| CY2011 | us-gaap |
Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
|
-543000 | USD |
| CY2011 | us-gaap |
Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
|
-69382000 | USD |
| CY2013 | us-gaap |
Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
|
680000 | USD |
| CY2013 | us-gaap |
Share Based Compensation
ShareBasedCompensation
|
8668000 | USD |
| CY2013 | us-gaap |
Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
|
333000 | USD |
| CY2013 | us-gaap |
Accretion Expense
AccretionExpense
|
160000 | USD |
| CY2013 | us-gaap |
Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
|
1832000 | USD |
| CY2013 | us-gaap |
Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
|
-1131000 | USD |
| CY2013 | insm |
Increase Decrease In Accrued Liabilities And Deferred Rent Credit
IncreaseDecreaseInAccruedLiabilitiesAndDeferredRentCredit
|
2156000 | USD |
| CY2013 | insm |
Increase Decrease In Accrued Lease Expenses
IncreaseDecreaseInAccruedLeaseExpenses
|
-255000 | USD |
| CY2013 | us-gaap |
Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
|
632000 | USD |
| CY2013 | us-gaap |
Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
|
-46664000 | USD |
| CY2013 | us-gaap |
Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
|
826000 | USD |
| CY2013 | us-gaap |
Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
|
2000 | USD |
| CY2013 | us-gaap |
Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
|
68447000 | USD |
| CY2013 | us-gaap |
Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
|
23112000 | USD |
| CY2013 | us-gaap |
Interest Paid
InterestPaid
|
1809000 | USD |
| CY2012 | us-gaap |
Proceeds From Issuance Of Debt
ProceedsFromIssuanceOfDebt
|
20000000 | USD |
| CY2012 | us-gaap |
Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
|
561000 | USD |
| CY2012 | us-gaap |
Share Based Compensation
ShareBasedCompensation
|
2981000 | USD |
| CY2012 | us-gaap |
Gain On Sale Of Investments
GainOnSaleOfInvestments
|
833000 | USD |
| CY2012 | us-gaap |
Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
|
236000 | USD |
| CY2012 | us-gaap |
Accretion Expense
AccretionExpense
|
44000 | USD |
| CY2012 | us-gaap |
Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
|
-757000 | USD |
| CY2012 | us-gaap |
Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
|
180000 | USD |
| CY2012 | insm |
Increase Decrease In Accrued Liabilities And Deferred Rent Credit
IncreaseDecreaseInAccruedLiabilitiesAndDeferredRentCredit
|
922000 | USD |
| CY2012 | insm |
Increase Decrease In Accrued Lease Expenses
IncreaseDecreaseInAccruedLeaseExpenses
|
-259000 | USD |
| CY2012 | us-gaap |
Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
|
1412000 | USD |
| CY2012 | us-gaap |
Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
|
-31012000 | USD |
| CY2012 | us-gaap |
Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
|
290000 | USD |
| CY2012 | us-gaap |
Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
|
5000 | USD |
| CY2012 | us-gaap |
Proceeds From Sale Of Short Term Investments
ProceedsFromSaleOfShortTermInvestments
|
81464000 | USD |
| CY2012 | us-gaap |
Payments To Acquire Short Term Investments
PaymentsToAcquireShortTermInvestments
|
19657000 | USD |
| CY2012 | us-gaap |
Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
|
61522000 | USD |
| CY2012 | us-gaap |
Repayments Of Long Term Capital Lease Obligations
RepaymentsOfLongTermCapitalLeaseObligations
|
120000 | USD |
| CY2013 | us-gaap |
Income Taxes Paid Net
IncomeTaxesPaidNet
|
1221000 | USD |
| CY2012 | us-gaap |
Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
|
25658000 | USD |
| CY2012 | us-gaap |
Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
|
214000 | USD |
| CY2012 | us-gaap |
Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
|
328000 | USD |
| CY2011 | insm |
Increase Decrease In Accrued Liabilities And Deferred Rent Credit
IncreaseDecreaseInAccruedLiabilitiesAndDeferredRentCredit
|
667000 | USD |
| CY2011 | insm |
Increase Decrease In Accrued Lease Expenses
IncreaseDecreaseInAccruedLeaseExpenses
|
1201000 | USD |
| CY2012 | us-gaap |
Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
|
45424000 | USD |
| CY2012 | us-gaap |
Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
|
75934000 | USD |
| CY2012 | us-gaap |
Interest Paid
InterestPaid
|
398000 | USD |
| CY2012 | us-gaap |
Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
|
450000 | USD |
| CY2012 | insm |
Fair Value Of Warrants In Connection With Debt
FairValueOfWarrantsInConnectionWithDebt
|
790000 | USD |
| CY2011 | us-gaap |
Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
|
884000 | USD |
| CY2011 | us-gaap |
Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
|
343000 | USD |
| CY2011 | us-gaap |
Share Based Compensation
ShareBasedCompensation
|
1599000 | USD |
| CY2011 | us-gaap |
Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
|
-322000 | USD |
| CY2011 | us-gaap |
Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
|
-402000 | USD |
| CY2011 | us-gaap |
Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
|
-30205000 | USD |
| CY2011 | us-gaap |
Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
|
979000 | USD |
| CY2011 | us-gaap |
Proceeds From Sale Of Short Term Investments
ProceedsFromSaleOfShortTermInvestments
|
36500000 | USD |
| CY2011 | us-gaap |
Payments To Acquire Short Term Investments
PaymentsToAcquireShortTermInvestments
|
1161000 | USD |
| CY2011 | us-gaap |
Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
|
34360000 | USD |
| CY2011 | us-gaap |
Repayments Of Long Term Capital Lease Obligations
RepaymentsOfLongTermCapitalLeaseObligations
|
82000 | USD |
| CY2011 | us-gaap |
Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
|
32000 | USD |
| CY2011 | us-gaap |
Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
|
-50000 | USD |
| CY2011 | us-gaap |
Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
|
4105000 | USD |
| CY2011 | us-gaap |
Interest Paid
InterestPaid
|
10000 | USD |
| CY2011 | us-gaap |
Capital Lease Obligations Incurred
CapitalLeaseObligationsIncurred
|
198000 | USD |
| CY2011 | us-gaap |
Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
|
543000 | USD |
| CY2011 | insm |
Equity Instrument Convertible Beneficial Conversion Feature
EquityInstrumentConvertibleBeneficialConversionFeature
|
-9175000 | USD |
| CY2011 | us-gaap |
Conversion Of Stock Amount Converted1
ConversionOfStockAmountConverted1
|
918000 | USD |
| CY2013Q4 | insm |
Fair Value Of Warrants Outstanding
FairValueOfWarrantsOutstanding
|
790000 | USD |
| CY2011Q4 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
14848000 | USD |
| CY2010Q4 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
10743000 | USD |
| CY2011Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
134267000 | USD |
| CY2011 | us-gaap |
Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
|
32000 | USD |
| CY2011 | us-gaap |
Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
|
1599000 | USD |
| CY2010Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
192843000 | USD |
| CY2012 | us-gaap |
Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
|
-450000 | USD |
| CY2012 | us-gaap |
Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
|
214000 | USD |
| CY2012 | us-gaap |
Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
|
25658000 | USD |
| CY2012 | us-gaap |
Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
|
1777000 | USD |
| CY2013 | us-gaap |
Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
|
1626000 | USD |
| CY2013 | us-gaap |
Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
|
67017000 | USD |
| CY2013 | us-gaap |
Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
|
6501000 | USD |
| CY2012 | insm |
Stock Issued During Period Value Warrants Granted In Connection With Debt
StockIssuedDuringPeriodValueWarrantsGrantedInConnectionWithDebt
|
790000 | USD |
| CY2011 | us-gaap |
Defined Contribution Plan Employer Discretionary Contribution Amount
DefinedContributionPlanEmployerDiscretionaryContributionAmount
|
0 | USD |
| CY2013Q4 | us-gaap |
Operating Leases Future Minimum Payments Due Current
OperatingLeasesFutureMinimumPaymentsDueCurrent
|
1237000 | USD |
| CY2013Q4 | us-gaap |
Operating Leases Future Minimum Payments Due Thereafter
OperatingLeasesFutureMinimumPaymentsDueThereafter
|
460000 | USD |
| CY2013Q1 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-14309000 | USD |
| CY2013Q2 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-8270000 | USD |
| CY2013Q3 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-16842000 | USD |
| CY2013Q4 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-15594000 | USD |
| CY2012Q1 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-7264000 | USD |
| CY2012Q2 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-9983000 | USD |
| CY2012Q3 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-9353000 | USD |
| CY2012Q4 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-15838000 | USD |
| CY2013Q1 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-13678000 | USD |
| CY2013Q2 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-8854000 | USD |
| CY2013Q3 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-17327000 | USD |
| CY2013Q4 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-16214000 | USD |
| CY2012Q1 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-6845000 | USD |
| CY2012Q2 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-9696000 | USD |
| CY2012Q3 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-9382000 | USD |
| CY2012Q4 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-15451000 | USD |
| CY2012Q1 | us-gaap |
Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
|
-0.28 | |
| CY2012Q2 | us-gaap |
Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
|
-0.39 | |
| CY2013Q1 | us-gaap |
Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
|
-0.43 | |
| CY2013Q2 | us-gaap |
Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
|
-0.28 | |
| CY2013Q3 | us-gaap |
Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
|
-0.46 | |
| CY2013Q4 | us-gaap |
Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
|
-0.41 | |
| CY2012Q3 | us-gaap |
Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
|
-0.38 | |
| CY2012Q4 | us-gaap |
Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
|
-0.49 | |
| CY2012Q3 | us-gaap |
Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
|
6304102 | shares |
| CY2012Q3 | us-gaap |
Share Price
SharePrice
|
4.07 | |
| CY2012Q3 | us-gaap |
Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
|
25700000 | USD |
| CY2011 | us-gaap |
Debt Instrument Convertible Beneficial Conversion Feature
DebtInstrumentConvertibleBeneficialConversionFeature
|
9200000 | USD |
| CY2011 | us-gaap |
Goodwill Impairment Loss
GoodwillImpairmentLoss
|
6300000 | USD |
| CY2012Q4 | insm |
Unrecognized Tax Benefits Reserves
UnrecognizedTaxBenefitsReserves
|
0 | USD |
| CY2013Q4 | insm |
Unrecognized Tax Benefits Reserves
UnrecognizedTaxBenefitsReserves
|
0 | USD |
| CY2013Q4 | us-gaap |
Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued
|
0 | USD |
| CY2012Q4 | us-gaap |
Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued
|
0 | USD |
| CY2013Q4 | us-gaap |
Long Term Debt Maturities Repayments Of Principal In Next Twelve Months
LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths
|
3626000 | USD |
| CY2012Q4 | us-gaap |
Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
|
4000 | USD |
| CY2011 | us-gaap |
Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
|
1000 | USD |
| CY2013 | insm |
Adjustments To Additional Paid In Capital Sharebased Compensation For Liability Awards
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationForLiabilityAwards
|
3371000 | USD |
| CY2013 | us-gaap |
Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
|
100000 | USD |
